Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon&beta; 1a

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

287

HTML

1524

Figures (1-3)

202

Sum=2013

Jul 14, 2007 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 14, 2007; 13(26): 3638-3640
Published online Jul 14, 2007. doi: 10.3748/wjg.v13.i26.3638

Figure 1 T₁-weighted axial MRI showing contrast enhancing lesion indicative of inflammatory activity in MS.

Figure 2 Severe ulcerative colitis on colonoscopy.

Figure 3 Presence of ulcerative colitis hallmark features on histology (HE, x 5).

Citation: Schott E, Paul F, Wuerfel JT, Zipp F, Rudolph B, Wiedenmann B, Baumgart DC. Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferonβ 1a. World J Gastroenterol 2007; 13(26): 3638-3640
URL: https://www.wjgnet.com/1007-9327/full/v13/i26/3638.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i26.3638